港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

中國生物製藥

5.420

-0.055-1.00%

成交量：5,935.36萬

成交額：3.24億

市值：1,012.62億

市盈率：35.73

高：5.530

開：5.455

低：5.415

收：5.475

52周最高：8.598

52周最低：4.136

股本：186.83億

香港流通股本：186.83億

量比：0.65

換手率：0.32%

股息：0.12

股息率：2.22%

每股收益(LYR):0.152

淨資產收益率：14.07%

總資產收益率：7.51%

市淨率：2.66

市盈率(LYR):35.73

市銷率: 2.57

資料載入中...

總覽公司新聞資訊公告

中國生物製藥(01177)與Cipla就TQB2102訂立獨家授權協議

中國生物製藥與Cipla簽署TQB2102獨家授權協議最高里程碑付款1.23億美元

中國生物製藥：有望獲得高達1.23億美元里程碑付款及分層雙位數特許權使用費

中國生物製藥：Cipla獲Tqb2102印度、南非及五大市場獨家授權

異動解讀｜中國生物製藥盤中下跌3.04%，報5.405港元

中國生物製藥（01177）披露Kylo-11 I期臨床結果：「一年一次」給藥潛力獲臨床證據支持

中國生物製藥：創新藥Kylo-11 I期臨床數據在ESC 2026及《柳葉刀》公布

南方财经网

中國生物製藥：LM-364獲NMPA及FDA臨床試驗批准

南方财经网

中國生物製藥（01177）自主研發LM-364獲NMPA臨床試驗默示許可

中國生物製藥LM-364「Nectin-4TME ADC」獲NMPA臨床試驗批准，劍指晚期實體瘤

異動解讀｜中國生物製藥盤中下跌3.05%，報5.56港元

【券商聚焦】國投證券：創新藥有望開啓新一輪高景氣周期

中國生物製藥減重「貼片」新藥在美國獲批臨床

異動解讀｜中國生物製藥盤中上漲3.29%，GLP-1減重貼片獲美國FDA臨床批准

中國生物製藥減重「貼片」新藥在美國獲批臨床；益方生物重啓港股上市申請｜醫藥早參

每日经济新闻

【券商聚焦】交銀國際：中國內地mRNA疫苗產業整體低估嚴重

中國生物製藥(01177.HK)創新ActRII A/B單抗獲准開展臨床研究

阿斯达克财经

中國生物製藥(01177)：TQF6422注射液「ActRII A/B單抗」臨床試驗申請獲NMPA批准

中國生物製藥(01177)自主研發TQF6422注射液獲NMPA臨床試驗許可

中國生物製藥Tqf6422注射液「Actrii a/B單抗」臨床試驗申請獲國家藥監局批准

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/01177/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01177","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01177\",,,,,undefined,":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"中國生物製藥","latestPrice":5.42,"timestamp":1789459709002,"preClose":5.475,"halted":0,"volume":59353554,"delay":0,"changeRate":-0.01004566210045657,"floatShares":18683000000,"shares":18683000000,"eps":0.15170132117922086,"marketStatus":"未開盤","change":-0.055,"latestTime":"09-15 16:08:29","open":5.455,"high":5.53,"low":5.415,"amount":324239763,"amplitude":0.021005,"askPrice":5.42,"askSize":1587000,"bidPrice":5.415,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":0.15457642229788032,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789522200000},"marketStatusCode":0,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":5.475,"dividendRate":0.022159,"openAndCloseTimeList":[[1789435800000,1789444800000],[1789448400000,1789459200000]],"volumeRatio":0.6518664394118316,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.459,"impliedVolPercentile":0.6531},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01177\",,,,,undefined,":{"symbol":"01177","floatShares":18683000000,"roa":"7.51%","roe":"14.07%","lyrEps":0.151703,"volumeRatio":0.6518664394118316,"shares":18683000000,"dividePrice":0.1201,"high":5.53,"amplitude":0.021005,"preClose":5.475,"low":5.415,"week52Low":4.136,"pbRate":"2.66","psRate":"2.57","week52High":8.598,"institutionHeld":0,"latestPrice":5.42,"committee":-0.996226,"eps":0.1517028549081752,"divideRate":0.022159,"volume":59353554,"delay":0,"ttmEps":0.15457798509464896,"open":5.455,"prevYearClose":6.032,"prevWeekClose":5.25,"prevMonthClose":5.38,"prevQuarterClose":4.353,"fiveDayClose":5.845,"twentyDayClose":4.733,"sixtyDayClose":4.343,"dividendFrequency":"Q","dividendGrowthYears":1,"dividendGrowthRate":0.5,"fiveYearAvgDividendRate":0.01853830546296888},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01177\",params:#limit:5,,,undefined,":[{"date":"2026-09-01","symbol":"01177","amount":0.07,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-09-02","defaultRemindTime":1788226200000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-24","payableDate":"2026-09-02","currency":"HKD","dateTimestamp":1788192000000,"payDate":"2026-09-24"},{"date":"2026-08-19","symbol":"01177","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-06-24","symbol":"01177","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-06-25","defaultRemindTime":1782264600000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-20","payableDate":"2026-06-25","currency":"HKD","dateTimestamp":1782230400000,"payDate":"2026-07-20"},{"market":"HK","date":"2026-03-26","symbol":"01177","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774454400000,"reportTimeType":"pre","actualEps":null},{"date":"2025-08-29","symbol":"01177","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-09-01","defaultRemindTime":1756431000000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-01","currency":"HKD","dateTimestamp":1756396800000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01177\",market:\"HK\",,,undefined,":[{"executeDate":"2016-12-05","recordDate":"2016-12-06","paymentDate":"2016-12-19","value":0.015,"currency":"HKD"},{"executeDate":"2017-06-28","recordDate":"2017-06-29","paymentDate":"2017-07-13","value":0.015,"currency":"HKD"},{"executeDate":"2017-07-06","recordDate":"2017-07-07","paymentDate":"2017-07-20","value":0.015,"currency":"HKD"},{"executeDate":"2017-09-12","recordDate":"2017-09-13","paymentDate":"2017-09-29","value":0.02,"currency":"HKD"},{"executeDate":"2017-11-28","recordDate":"2017-11-29","paymentDate":"2017-12-15","value":0.02,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01177\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5833,"hold":0.0417,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":24,"updateTime":1787673600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01177\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01177","date":"2026-09-14","current":35.063012,"percent":0.938161,"low":4.081901,"twenty":8.75286,"median":20.39496,"eighty":29.260663,"high":42.521413,"avg":19.605065,"sd":10.069554,"marketCap":97509490140},"quantilePoints":[{"date":"2021-09-17","current":9.908289,"twenty":28.128178,"median":45.28035,"eighty":51.669892,"marketCap":119370291322},{"date":"2021-09-24","current":9.779132,"twenty":27.82689,"median":44.686819,"eighty":51.590126,"marketCap":117868778224},{"date":"2021-09-30","current":10.025874,"twenty":27.27478,"median":44.601887,"eighty":51.56014,"marketCap":121247182695},{"date":"2021-10-08","current":9.186602,"twenty":27.046772,"median":44.130413,"eighty":51.548113,"marketCap":111092433281},{"date":"2021-10-15","current":9.318231,"twenty":26.569923,"median":36.694857,"eighty":51.507128,"marketCap":112761505517},{"date":"2021-10-22","current":9.220183,"twenty":26.170808,"median":35.563772,"eighty":51.434346,"marketCap":112376076242},{"date":"2021-10-29","current":8.887419,"twenty":25.602517,"median":35.364793,"eighty":51.352853,"marketCap":108052495084},{"date":"2021-11-05","current":8.456886,"twenty":10.558373,"median":34.998178,"eighty":51.164241,"marketCap":102987534377},{"date":"2021-11-12","current":8.560231,"twenty":10.416496,"median":34.764786,"eighty":50.984786,"marketCap":104675854613},{"date":"2021-11-19","current":8.91034,"twenty":10.070918,"median":34.408066,"eighty":50.914517,"marketCap":108802859634},{"date":"2021-11-26","current":8.631049,"twenty":9.844574,"median":32.881851,"eighty":50.794169,"marketCap":105426219162},{"date":"2021-12-03","current":8.737756,"twenty":9.729778,"median":31.787963,"eighty":50.680984,"marketCap":106926948261},{"date":"2021-12-10","current":8.646346,"twenty":9.412104,"median":31.673805,"eighty":50.542589,"marketCap":105988992574},{"date":"2021-12-17","current":8.284795,"twenty":9.319774,"median":31.39672,"eighty":50.326681,"marketCap":101486805279},{"date":"2021-12-24","current":8.338086,"twenty":9.192112,"median":31.22719,"eighty":50.196443,"marketCap":102237169828},{"date":"2021-12-31","current":8.333922,"twenty":9.141505,"median":30.384431,"eighty":50.006669,"marketCap":102408380965},{"date":"2022-01-07","current":8.978555,"twenty":8.282213,"median":8.578854,"eighty":8.931855,"marketCap":109910826457},{"date":"2022-01-14","current":9.402408,"twenty":8.355848,"median":8.935267,"eighty":9.27511,"marketCap":115350099439},{"date":"2022-01-21","current":9.274157,"twenty":8.495499,"median":9.134096,"eighty":9.308362,"marketCap":114037171478},{"date":"2022-01-28","current":8.181531,"twenty":8.355848,"median":8.96544,"eighty":9.254892,"marketCap":100345208455},{"date":"2022-02-04","current":8.353845,"twenty":8.333922,"median":8.935267,"eighty":9.242048,"marketCap":102408380965},{"date":"2022-02-11","current":8.398082,"twenty":8.353845,"median":8.585644,"eighty":9.231359,"marketCap":103158625515},{"date":"2022-02-18","current":8.372232,"twenty":8.353845,"median":8.539109,"eighty":9.218737,"marketCap":103346186652},{"date":"2022-02-25","current":7.955221,"twenty":8.320426,"median":8.459805,"eighty":9.215937,"marketCap":98440722082},{"date":"2022-03-04","current":6.997914,"twenty":8.192451,"median":8.399622,"eighty":9.134096,"marketCap":86627835432},{"date":"2022-03-11","current":6.659587,"twenty":7.910139,"median":8.387341,"eighty":9.033931,"marketCap":82315194274},{"date":"2022-03-18","current":7.006091,"twenty":7.259352,"median":8.362252,"eighty":8.978555,"marketCap":86252823158},{"date":"2022-03-25","current":7.371317,"twenty":7.236339,"median":8.351954,"eighty":8.952325,"marketCap":90752970453},{"date":"2022-04-01","current":4.675869,"twenty":7.058972,"median":8.308293,"eighty":8.918209,"marketCap":84106186785},{"date":"2022-04-08","current":4.547747,"twenty":6.942633,"median":8.219605,"eighty":8.830117,"marketCap":81837075137},{"date":"2022-04-14","current":4.387704,"twenty":6.616876,"median":8.186991,"eighty":8.674624,"marketCap":78826492940},{"date":"2022-04-22","current":4.248774,"twenty":6.241316,"median":8.048348,"eighty":8.582928,"marketCap":74903847557},{"date":"2022-04-29","current":4.469038,"twenty":4.692503,"median":7.744517,"eighty":8.568318,"marketCap":77518944479},{"date":"2022-05-06","current":4.081901,"twenty":4.488006,"median":7.565869,"eighty":8.547152,"marketCap":70215607624},{"date":"2022-05-13","current":4.322075,"twenty":4.384485,"median":7.532014,"eighty":8.525703,"marketCap":73016762184},{"date":"2022-05-20","current":4.632904,"twenty":4.384485,"median":7.412742,"eighty":8.466335,"marketCap":79366045852},{"date":"2022-05-27","current":4.680568,"twenty":4.387704,"median":7.259352,"eighty":8.459805,"marketCap":80113020401},{"date":"2022-06-02","current":4.525356,"twenty":4.432565,"median":7.058972,"eighty":8.419371,"marketCap":77872096754},{"date":"2022-06-10","current":4.621539,"twenty":4.4352,"median":7.002002,"eighty":8.402782,"marketCap":78992558577},{"date":"2022-06-17","current":4.735988,"twenty":4.463986,"median":6.662821,"eighty":8.398698,"marketCap":80859994950},{"date":"2022-06-24","current":5.142082,"twenty":4.471352,"median":6.514843,"eighty":8.397313,"marketCap":88142996805},{"date":"2022-06-30","current":5.423776,"twenty":4.472615,"median":6.245656,"eighty":8.391253,"marketCap":92811587738},{"date":"2022-07-08","current":5.73435,"twenty":4.494949,"median":5.753227,"eighty":8.378276,"marketCap":98227153219},{"date":"2022-07-15","current":5.413863,"twenty":4.510715,"median":5.74317,"eighty":8.371172,"marketCap":91877869551},{"date":"2022-07-22","current":5.179385,"twenty":4.519814,"median":5.724312,"eighty":8.360609,"marketCap":87956253168},{"date":"2022-07-29","current":4.986361,"twenty":4.532767,"median":5.592688,"eighty":8.353922,"marketCap":84781611334},{"date":"2022-08-05","current":4.966061,"twenty":4.543731,"median":5.423776,"eighty":8.35271,"marketCap":84221380422},{"date":"2022-08-12","current":4.728381,"twenty":4.557367,"median":5.285894,"eighty":8.341135,"marketCap":80299764039},{"date":"2022-08-19","current":4.642899,"twenty":4.56463,"median":5.258084,"eighty":8.325824,"marketCap":78058840391},{"date":"2022-08-26","current":8.493761,"twenty":4.56647,"median":5.277824,"eighty":8.341135,"marketCap":78058840391},{"date":"2022-09-02","current":8.238862,"twenty":4.578556,"median":5.413863,"eighty":8.355149,"marketCap":75444429469},{"date":"2022-09-09","current":8.208746,"twenty":4.591042,"median":5.480211,"eighty":8.353922,"marketCap":74882486287},{"date":"2022-09-16","current":8.11962,"twenty":4.598745,"median":5.696236,"eighty":8.353089,"marketCap":73385034348},{"date":"2022-09-23","current":7.794047,"twenty":4.606594,"median":5.727415,"eighty":8.344741,"marketCap":69090235901},{"date":"2022-09-30","current":7.678478,"twenty":4.613732,"median":5.752609,"eighty":8.328524,"marketCap":68195810112},{"date":"2022-10-07","current":7.78297,"twenty":4.623812,"median":5.823839,"eighty":8.317285,"marketCap":69119872580},{"date":"2022-10-14","current":8.22397,"twenty":4.634903,"median":6.267354,"eighty":8.303007,"marketCap":72261684970},{"date":"2022-10-21","current":8.894846,"twenty":4.643031,"median":6.606198,"eighty":8.353467,"marketCap":77621247282},{"date":"2022-10-28","current":8.400958,"twenty":4.643734,"median":6.721508,"eighty":8.371879,"marketCap":73185747437},{"date":"2022-11-04","current":8.90828,"twenty":4.646216,"median":7.016023,"eighty":8.396002,"marketCap":78360497256},{"date":"2022-11-11","current":9.100313,"twenty":4.655414,"median":7.236339,"eighty":8.407643,"marketCap":80763059672},{"date":"2022-11-18","current":9.403245,"twenty":4.664392,"median":7.335813,"eighty":8.46442,"marketCap":83165622088},{"date":"2022-11-25","current":8.930799,"twenty":4.668952,"median":7.531332,"eighty":8.525171,"marketCap":78360497256},{"date":"2022-12-02","current":9.296925,"twenty":4.676809,"median":7.555053,"eighty":8.584286,"marketCap":82980809594},{"date":"2022-12-09","current":9.313941,"twenty":4.687945,"median":7.567538,"eighty":8.707566,"marketCap":83904872062},{"date":"2022-12-16","current":9.397407,"twenty":4.719639,"median":7.647562,"eighty":8.81303,"marketCap":84459309543},{"date":"2022-12-23","current":9.086129,"twenty":4.729099,"median":7.698595,"eighty":8.889427,"marketCap":81687122140},{"date":"2022-12-30","current":9.281716,"twenty":4.731254,"median":7.710864,"eighty":8.915011,"marketCap":84459309543},{"date":"2023-01-06","current":9.328055,"twenty":4.734382,"median":7.731498,"eighty":8.96145,"marketCap":85752996997},{"date":"2023-01-13","current":9.843426,"twenty":4.737165,"median":7.764775,"eighty":9.024693,"marketCap":92221434271},{"date":"2023-01-20","current":9.630169,"twenty":4.739933,"median":7.808834,"eighty":9.11954,"marketCap":89449246868},{"date":"2023-01-27","current":9.76745,"twenty":4.741255,"median":7.828,"eighty":9.134096,"marketCap":90742934323},{"date":"2023-02-03","current":9.242159,"twenty":4.749977,"median":7.910139,"eighty":9.14912,"marketCap":86307434478},{"date":"2023-02-10","current":8.939647,"twenty":4.760926,"median":7.994821,"eighty":9.145292,"marketCap":82980809594},{"date":"2023-02-17","current":8.502405,"twenty":4.779418,"median":8.042416,"eighty":9.134096,"marketCap":78175684763},{"date":"2023-02-24","current":8.382439,"twenty":4.784909,"median":8.105078,"eighty":9.13158,"marketCap":76130387334},{"date":"2023-03-03","current":8.590767,"twenty":4.786195,"median":8.138516,"eighty":9.111513,"marketCap":78525547250},{"date":"2023-03-10","current":8.613919,"twenty":8.572182,"median":8.603737,"eighty":8.631438,"marketCap":78156015263},{"date":"2023-03-17","current":8.854074,"twenty":8.686159,"median":14.627146,"eighty":50.137268,"marketCap":81112271159},{"date":"2023-03-24","current":8.653874,"twenty":8.680699,"median":14.555372,"eighty":50.059787,"marketCap":80188441192},{"date":"2023-03-31","current":8.841045,"twenty":8.682095,"median":14.465882,"eighty":50.052946,"marketCap":81297037153},{"date":"2023-04-06","current":26.385992,"twenty":8.683492,"median":14.468662,"eighty":50.046105,"marketCap":76623190314},{"date":"2023-04-14","current":29.091238,"twenty":8.680699,"median":14.463101,"eighty":49.815888,"marketCap":84562460636},{"date":"2023-04-21","current":28.343601,"twenty":8.680699,"median":14.463101,"eighty":49.757313,"marketCap":82346850314},{"date":"2023-04-28","current":27.787899,"twenty":8.680699,"median":14.463101,"eighty":49.691641,"marketCap":80131239992},{"date":"2023-05-05","current":27.186497,"twenty":8.680699,"median":14.463101,"eighty":49.389192,"marketCap":78525547250},{"date":"2023-05-12","current":26.022356,"twenty":8.680699,"median":14.463101,"eighty":49.1783,"marketCap":74645461386},{"date":"2023-05-19","current":25.609528,"twenty":8.680699,"median":14.463101,"eighty":48.945058,"marketCap":72428269463},{"date":"2023-05-25","current":25.452944,"twenty":8.682095,"median":14.465882,"eighty":48.625163,"marketCap":71689205489},{"date":"2023-06-02","current":24.881313,"twenty":8.680699,"median":14.463101,"eighty":48.313875,"marketCap":69841545554},{"date":"2023-06-09","current":25.44461,"twenty":8.680699,"median":14.463101,"eighty":48.13438,"marketCap":71319673502},{"date":"2023-06-16","current":25.567055,"twenty":8.680699,"median":14.463101,"eighty":47.936748,"marketCap":71319673502},{"date":"2023-06-23","current":22.156893,"twenty":8.680699,"median":14.463101,"eighty":47.800493,"marketCap":61469866445},{"date":"2023-06-30","current":22.891344,"twenty":8.680699,"median":14.463101,"eighty":47.612323,"marketCap":62932979993},{"date":"2023-07-07","current":23.003349,"twenty":8.682095,"median":14.465882,"eighty":47.475199,"marketCap":63117534187},{"date":"2023-07-14","current":23.348328,"twenty":8.682095,"median":14.465882,"eighty":47.339122,"marketCap":64963076122},{"date":"2023-07-21","current":23.124147,"twenty":8.682095,"median":14.465882,"eighty":47.120587,"marketCap":64040305154},{"date":"2023-07-28","current":23.882752,"twenty":8.682095,"median":14.465882,"eighty":46.941508,"marketCap":66070401283},{"date":"2023-08-04","current":22.5111,"twenty":8.682095,"median":14.465882,"eighty":46.556098,"marketCap":62379317413},{"date":"2023-08-11","current":21.031429,"twenty":8.682095,"median":14.465882,"eighty":46.490275,"marketCap":57950016768},{"date":"2023-08-18","current":20.109761,"twenty":8.682095,"median":14.465882,"eighty":46.446515,"marketCap":55013725665},{"date":"2023-08-25","current":27.35707,"twenty":8.682095,"median":14.465882,"eighty":46.446515,"marketCap":55381710452},{"date":"2023-09-01","current":26.972418,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54829733271},{"date":"2023-09-08","current":26.744198,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":53725778910},{"date":"2023-09-15","current":26.901969,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54461748484},{"date":"2023-09-22","current":26.83754,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54093763697},{"date":"2023-09-29","current":25.789185,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52069847368},{"date":"2023-10-06","current":25.16334,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":50781900614},{"date":"2023-10-13","current":25.840139,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52069847368},{"date":"2023-10-20","current":24.416834,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":49125969072},{"date":"2023-10-27","current":26.714516,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53725778910},{"date":"2023-11-03","current":30.567338,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":61637451832},{"date":"2023-11-10","current":31.39511,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63293383374},{"date":"2023-11-17","current":34.642006,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":70469086721},{"date":"2023-11-24","current":33.820877,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":69365132360},{"date":"2023-12-01","current":33.323855,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":68629162786},{"date":"2023-12-08","current":30.229794,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":62005436619},{"date":"2023-12-15","current":30.948108,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63845360554},{"date":"2023-12-22","current":28.291375,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":58325588749},{"date":"2023-12-29","current":30.804548,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63845360554},{"date":"2024-01-05","current":29.592871,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":60901482258},{"date":"2024-01-12","current":28.772914,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":59245550716},{"date":"2024-01-19","current":26.217575,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53909771304},{"date":"2024-01-26","current":25.960692,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53173801730},{"date":"2024-02-02","current":25.634057,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52437832156},{"date":"2024-02-09","current":26.045455,"twenty":8.684903,"median":14.482873,"eighty":46.363102,"marketCap":53541786517},{"date":"2024-02-16","current":28.187439,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":57957603961},{"date":"2024-02-23","current":28.246863,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":57773611568},{"date":"2024-03-01","current":27.959549,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":57221634387},{"date":"2024-03-08","current":26.060017,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":53357794123},{"date":"2024-03-15","current":29.321008,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":59981520290},{"date":"2024-03-22","current":27.457347,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":56117680026},{"date":"2024-03-28","current":27.274509,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":55565702846},{"date":"2024-04-05","current":20.502088,"twenty":8.68491,"median":14.545212,"eighty":46.385567,"marketCap":51738890207},{"date":"2024-04-12","current":19.836504,"twenty":8.684917,"median":14.622337,"eighty":46.379948,"marketCap":50087649030},{"date":"2024-04-19","current":17.00797,"twenty":8.684917,"median":14.824165,"eighty":46.379948,"marketCap":42908870597},{"date":"2024-04-26","current":20.158221,"twenty":8.685111,"median":15.006965,"eighty":46.368715,"marketCap":50793833997},{"date":"2024-05-03","current":20.900402,"twenty":8.685111,"median":17.666939,"eighty":46.368715,"marketCap":52627546416},{"date":"2024-05-10","current":22.594528,"twenty":8.68601,"median":19.495478,"eighty":46.368715,"marketCap":57028456221},{"date":"2024-05-17","current":22.482225,"twenty":8.68601,"median":19.836504,"eighty":46.368715,"marketCap":56661713737},{"date":"2024-05-24","current":20.929348,"twenty":8.68601,"median":20.158221,"eighty":46.368715,"marketCap":52627546416},{"date":"2024-05-31","current":20.689517,"twenty":8.68601,"median":20.438856,"eighty":46.368715,"marketCap":52077432691},{"date":"2024-06-07","current":20.788148,"twenty":8.707461,"median":20.694975,"eighty":46.368715,"marketCap":52260803932},{"date":"2024-06-14","current":20.150143,"twenty":8.757175,"median":20.694975,"eighty":46.368715,"marketCap":50610462756},{"date":"2024-06-21","current":19.02184,"twenty":8.763371,"median":20.705001,"eighty":46.368715,"marketCap":47676522886},{"date":"2024-06-28","current":19.542074,"twenty":8.763371,"median":20.705001,"eighty":46.368715,"marketCap":48960121579},{"date":"2024-07-05","current":20.717633,"twenty":8.763371,"median":20.708507,"eighty":46.368715,"marketCap":51894061449},{"date":"2024-07-12","current":21.125844,"twenty":8.763371,"median":20.717171,"eighty":46.368715,"marketCap":52994288900},{"date":"2024-07-19","current":20.833056,"twenty":8.763371,"median":20.76172,"eighty":46.368715,"marketCap":52260803932},{"date":"2024-07-26","current":20.391805,"twenty":8.763371,"median":20.774673,"eighty":46.368715,"marketCap":51343947723},{"date":"2024-08-02","current":20.403694,"twenty":8.763371,"median":20.774673,"eighty":46.368715,"marketCap":51343947723},{"date":"2024-08-09","current":20.920099,"twenty":8.763371,"median":20.788148,"eighty":46.368715,"marketCap":52994288900},{"date":"2024-08-16","current":13.474849,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":59895993625},{"date":"2024-08-23","current":12.806368,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":57165173247},{"date":"2024-08-30","current":13.085579,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":58803665474},{"date":"2024-09-06","current":12.836322,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":57711337322},{"date":"2024-09-13","current":13.073008,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":58621610782},{"date":"2024-09-20","current":13.560082,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":61170376468},{"date":"2024-09-27","current":14.842966,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":67360235991},{"date":"2024-10-04","current":16.724157,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":75552697126},{"date":"2024-10-10","current":15.372928,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":68998728218},{"date":"2024-10-18","current":15.412732,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":68816673526},{"date":"2024-10-25","current":14.435061,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":64447360921},{"date":"2024-11-01","current":14.669834,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":65539689073},{"date":"2024-11-08","current":14.122653,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":62808868695},{"date":"2024-11-15","current":13.694576,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60260103008},{"date":"2024-11-22","current":13.659673,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60078048317},{"date":"2024-11-29","current":13.461736,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":59167774857},{"date":"2024-12-06","current":13.618076,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":59713938933},{"date":"2024-12-13","current":13.728207,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60078048317},{"date":"2024-12-20","current":13.413238,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":58439556090},{"date":"2024-12-27","current":13.507288,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":58803665474},{"date":"2025-01-03","current":12.783861,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":55708735712},{"date":"2025-01-10","current":11.99376,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52067641874},{"date":"2025-01-17","current":12.179201,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52915350334},{"date":"2025-01-24","current":11.936992,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52187991566},{"date":"2025-01-28","current":11.667884,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":51278793107},{"date":"2025-02-07","current":12.358438,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":54006388485},{"date":"2025-02-14","current":13.472496,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":58734220474},{"date":"2025-02-21","current":13.855323,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":60734457084},{"date":"2025-02-28","current":13.401695,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":58552380782},{"date":"2025-03-07","current":13.845547,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":60734457084},{"date":"2025-03-14","current":14.627846,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":64189411230},{"date":"2025-03-21","current":17.171853,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":64449578833},{"date":"2025-03-28","current":17.828023,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":66776924735},{"date":"2025-04-03","current":18.607188,"twenty":8.758254,"median":20.78141,"eighty":46.385567,"marketCap":69557715461},{"date":"2025-04-11","current":17.2596,"twenty":8.758254,"median":20.717402,"eighty":46.357488,"marketCap":64091525617},{"date":"2025-04-17","current":17.642281,"twenty":8.758794,"median":20.705001,"eighty":46.234928,"marketCap":65669735088},{"date":"2025-04-25","current":18.971902,"twenty":8.757715,"median":20.631385,"eighty":45.993268,"marketCap":70679960108},{"date":"2025-05-02","current":19.027519,"twenty":8.758254,"median":20.543459,"eighty":45.790243,"marketCap":71037833324},{"date":"2025-05-09","current":18.60931,"twenty":8.757715,"median":20.427733,"eighty":45.434847,"marketCap":69964213677},{"date":"2025-05-16","current":19.119426,"twenty":8.757715,"median":20.391805,"eighty":44.686655,"marketCap":72469326187},{"date":"2025-05-23","current":19.674285,"twenty":8.757715,"median":20.317327,"eighty":41.07031,"marketCap":74795502089},{"date":"2025-05-30","current":20.853432,"twenty":8.757715,"median":20.194397,"eighty":35.483307,"marketCap":79626790502},{"date":"2025-06-06","current":21.257091,"twenty":8.757715,"median":20.194397,"eighty":34.895645,"marketCap":81375206580},{"date":"2025-06-13","current":25.825329,"twenty":8.757715,"median":20.194397,"eighty":34.568065,"marketCap":98902174152},{"date":"2025-06-20","current":23.349274,"twenty":8.757715,"median":20.194397,"eighty":34.239735,"marketCap":89244457327},{"date":"2025-06-27","current":24.730575,"twenty":8.758254,"median":20.194879,"eighty":33.775233,"marketCap":94788702171},{"date":"2025-07-04","current":26.12919,"twenty":8.758254,"median":20.194879,"eighty":33.366035,"marketCap":100154100407},{"date":"2025-07-11","current":27.696846,"twenty":8.758254,"median":20.194879,"eighty":32.285338,"marketCap":106056038466},{"date":"2025-07-18","current":32.252633,"twenty":8.758254,"median":20.194879,"eighty":31.824254,"marketCap":123404159430},{"date":"2025-07-25","current":31.530312,"twenty":8.758254,"median":20.194879,"eighty":31.686967,"marketCap":121079153527},{"date":"2025-08-01","current":34.30382,"twenty":8.758254,"median":20.194879,"eighty":31.686967,"marketCap":130915716960},{"date":"2025-08-08","current":34.40521,"twenty":8.758254,"median":20.194879,"eighty":31.686967,"marketCap":131631103392},{"date":"2025-08-15","current":36.610392,"twenty":8.758254,"median":20.194879,"eighty":31.686967,"marketCap":139858047354},{"date":"2025-08-22","current":34.687938,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":146117678629},{"date":"2025-08-29","current":34.269588,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":145044598982},{"date":"2025-09-05","current":37.687413,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":159352327612},{"date":"2025-09-12","current":36.43748,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":154344622591},{"date":"2025-09-19","current":35.745075,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":151304230258},{"date":"2025-09-26","current":33.677609,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":142183053256},{"date":"2025-10-03","current":35.441166,"twenty":8.758794,"median":20.195361,"eighty":31.667486,"marketCap":149985697470},{"date":"2025-10-10","current":32.996961,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":139438431498},{"date":"2025-10-17","current":30.821158,"twenty":8.758254,"median":20.194879,"eighty":31.578552,"marketCap":130142536065},{"date":"2025-10-24","current":29.45567,"twenty":8.758254,"median":20.194879,"eighty":31.368547,"marketCap":124421985029},{"date":"2025-10-31","current":29.876643,"twenty":8.758254,"median":20.194879,"eighty":31.265465,"marketCap":126388424448},{"date":"2025-11-07","current":28.922768,"twenty":8.758254,"median":20.194879,"eighty":31.041519,"marketCap":122276778391},{"date":"2025-11-14","current":30.949306,"twenty":8.758254,"median":20.194879,"eighty":30.811192,"marketCap":131215139384},{"date":"2025-11-21","current":28.685746,"twenty":8.758254,"median":20.194879,"eighty":30.274301,"marketCap":121561709511},{"date":"2025-11-28","current":29.632732,"twenty":8.758254,"median":20.194879,"eighty":30.134809,"marketCap":126030890008},{"date":"2025-12-05","current":28.700711,"twenty":8.758254,"median":20.194879,"eighty":29.953017,"marketCap":122276778391},{"date":"2025-12-12","current":28.480192,"twenty":8.758254,"median":20.194879,"eighty":29.835297,"marketCap":121561709511},{"date":"2025-12-19","current":27.452192,"twenty":8.758254,"median":20.194879,"eighty":29.72053,"marketCap":117450063454},{"date":"2025-12-24","current":26.742133,"twenty":8.758254,"median":20.194879,"eighty":29.657539,"marketCap":114768555156},{"date":"2026-01-02","current":26.38835,"twenty":8.757715,"median":20.194397,"eighty":29.590531,"marketCap":113695951837},{"date":"2026-01-09","current":28.268047,"twenty":8.757715,"median":20.194397,"eighty":29.448545,"marketCap":122098011171},{"date":"2026-01-16","current":28.671531,"twenty":8.757715,"median":20.194397,"eighty":29.382516,"marketCap":124243217809},{"date":"2026-01-23","current":27.377668,"twenty":8.757715,"median":20.194397,"eighty":29.317338,"marketCap":118522666773},{"date":"2026-01-30","current":27.294187,"twenty":8.757715,"median":20.194397,"eighty":29.254957,"marketCap":118701433993},{"date":"2026-02-06","current":26.569105,"twenty":8.757715,"median":20.194397,"eighty":29.040648,"marketCap":115841158475},{"date":"2026-02-13","current":26.580437,"twenty":8.758254,"median":20.194879,"eighty":28.989372,"marketCap":116556227355},{"date":"2026-02-20","current":27.149521,"twenty":8.757175,"median":20.182765,"eighty":28.920647,"marketCap":118880201213},{"date":"2026-02-27","current":24.431994,"twenty":8.757175,"median":20.182765,"eighty":28.791604,"marketCap":108154168021},{"date":"2026-03-06","current":24.95625,"twenty":8.757175,"median":20.182765,"eighty":28.714289,"marketCap":109584305780},{"date":"2026-03-13","current":24.112384,"twenty":8.757175,"median":20.182765,"eighty":28.621937,"marketCap":106366495822},{"date":"2026-03-20","current":24.326071,"twenty":8.757175,"median":20.182765,"eighty":28.49667,"marketCap":106902797482},{"date":"2026-03-27","current":39.697488,"twenty":8.757175,"median":20.182765,"eighty":28.410988,"marketCap":105331413864},{"date":"2026-04-02","current":42.422512,"twenty":8.757175,"median":20.182765,"eighty":28.410988,"marketCap":113102808993},{"date":"2026-04-10","current":39.371109,"twenty":8.757175,"median":20.182765,"eighty":28.410988,"marketCap":105777034635},{"date":"2026-04-17","current":39.886402,"twenty":8.757175,"median":20.182765,"eighty":28.410988,"marketCap":107206454022},{"date":"2026-04-24","current":37.756987,"twenty":8.757175,"median":20.182765,"eighty":28.410988,"marketCap":101488776474},{"date":"2026-04-30","current":36.001615,"twenty":8.757175,"median":20.182765,"eighty":28.410988,"marketCap":96795250666},{"date":"2026-05-08","current":35.921145,"twenty":8.756636,"median":20.171134,"eighty":28.381197,"marketCap":96914109689},{"date":"2026-05-15","current":35.555583,"twenty":8.756636,"median":20.171134,"eighty":28.381197,"marketCap":96180142796},{"date":"2026-05-22","current":34.487954,"twenty":8.757175,"median":20.182765,"eighty":28.410988,"marketCap":93078928399},{"date":"2026-05-29","current":32.854126,"twenty":8.756636,"median":20.171134,"eighty":28.381197,"marketCap":88977749561},{"date":"2026-06-05","current":30.636945,"twenty":8.756636,"median":20.171134,"eighty":28.381197,"marketCap":83093449490},{"date":"2026-06-12","current":30.920838,"twenty":8.756636,"median":20.171134,"eighty":28.381197,"marketCap":83806697983},{"date":"2026-06-18","current":30.056031,"twenty":8.757175,"median":20.182765,"eighty":28.410988,"marketCap":81658204703},{"date":"2026-06-26","current":28.093239,"twenty":8.756636,"median":20.171134,"eighty":28.356456,"marketCap":75952827955},{"date":"2026-07-03","current":31.235308,"twenty":8.756636,"median":20.171134,"eighty":28.356456,"marketCap":84510893077},{"date":"2026-07-10","current":34.242709,"twenty":8.756636,"median":20.171134,"eighty":28.356456,"marketCap":92534079129},{"date":"2026-07-17","current":32.696624,"twenty":8.756636,"median":20.171134,"eighty":28.356456,"marketCap":88670530138},{"date":"2026-07-24","current":33.805177,"twenty":8.756636,"median":20.171134,"eighty":28.356456,"marketCap":91697435785},{"date":"2026-07-31","current":32.95488,"twenty":8.75286,"median":20.164677,"eighty":28.435033,"marketCap":89560796505},{"date":"2026-08-07","current":33.316048,"twenty":8.75286,"median":20.164677,"eighty":28.534417,"marketCap":90718142782},{"date":"2026-08-14","current":31.1841,"twenty":8.75286,"median":20.164677,"eighty":28.704106,"marketCap":85020438034},{"date":"2026-08-21","current":35.765978,"twenty":8.75286,"median":20.164677,"eighty":28.870402,"marketCap":99646684444},{"date":"2026-08-28","current":35.757871,"twenty":8.75286,"median":20.164677,"eighty":29.018737,"marketCap":99646684444},{"date":"2026-09-04","current":35.360214,"twenty":8.75286,"median":20.294899,"eighty":29.069298,"marketCap":98578087292},{"date":"2026-09-11","current":33.494298,"twenty":8.75286,"median":20.37758,"eighty":29.255038,"marketCap":93502250819},{"date":"2026-09-14","current":34.93054,"twenty":8.75286,"median":20.39496,"eighty":29.260663,"marketCap":97509490140}],"updateTime":1789495701224},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01177\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663721600","title":"中國生物製藥(01177)與Cipla就TQB2102訂立獨家授權協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2663721600","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663721600?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:45","pubTimestamp":1788173143,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，本集团附属公司正大天晴药业集团股份有限公司已与Cipla Limited就本集团自主研发的HER2双抗ADC订立独家授权与供应协议(协议)。这是TQB2102达成的第二项区域授权合作。Cipla将负责授权区域内的本地临床开发、注册申报及商业化，正大天晴将继续负责TQB2102的生产及供应。Cipla在印度、南非及其他新兴市场深耕多年，拥有成熟的注册、医学及商业化体系，为加速TQB2102在授权区域内的开发和商业化奠定了坚实基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国生物制药(01177)与Cipla就TQB2102订立独家授权协议","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1515","BK1589","BK1521","IE00BZ08YT58.USD","01177","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138966107","title":"中國生物製藥與Cipla簽署TQB2102獨家授權協議 最高里程碑付款1.23億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138966107","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138966107?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:43","pubTimestamp":1788173028,"startTime":"0","endTime":"0","summary":"中国生物制药8月31日公告称，旗下子公司正大天晴药业集团股份有限公司已与Cipla Limited就自主研发的HER2双抗ADC rolditamig deuderuxtecan签订独家授权与供应协议。这是TQB2102的第二项区域授权合作，迄今已为公司累计带来约3,000万美元的首付款及里程碑付款。中国生物制药称，本次合作将依托Cipla在授权区域的本地化能力和市场准入优势，加速TQB2102在相关市场的开发及商业化，提升该药物的全球可及性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128741165","title":"中國生物製藥：有望獲得高達1.23億美元里程碑付款及分層雙位數特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1128741165","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128741165?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:40","pubTimestamp":1788172814,"startTime":"0","endTime":"0","summary":"中国生物制药集团披露了一项重磅利好——该公司将有资格收取最高达1.23亿美元的里程碑付款，并可享受分层式、双位数的特许权使用费分成。与此同时，分层双位数的特许权使用费结构，则意味着随着产品净销售额的阶梯式增长，集团所能分得的收益比例也将相应提升，从而在商业化放量阶段持续贡献可观的经常性收入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1589","BK1515","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1521","01177","IE00BZ08YT58.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171540168","title":"中國生物製藥：Cipla獲Tqb2102印度、南非及五大市場獨家授權","url":"https://stock-news.laohu8.com/highlight/detail?id=1171540168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171540168?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:40","pubTimestamp":1788172810,"startTime":"0","endTime":"0","summary":"中国生物制药宣布，其旗下产品Tqb2102已授予Cipla独家许可，覆盖印度、南非以及另外五个关键市场。这一战略合作显著拓宽了该药物的海外商业版图，为中国生物制药的全球化布局再添重要砝码。据悉，此次授权涉及的市场范围广泛，不仅包括南亚次大陆的核心区域，还延伸至非洲大陆的重要经济体。通过携手Cipla，中国生物制药旨在借助其在上述地区的成熟销售网络与本地化运营经验，加速推进Tqb2102的商业化进程。此举亦被视为中国创新药企加速“出海”、深度参与国际医药市场竞争的又一缩影。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1515","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1521","BK1191","IE00BZ08YT58.USD","HK0000165453.HKD","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140100824","title":"異動解讀｜中國生物製藥盤中下跌3.04%，報5.405港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1140100824","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140100824?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 09:54","pubTimestamp":1788141254,"startTime":"0","endTime":"0","summary":"8月31日，中国生物制药盘中下跌3.04%，报5.405港元/股，成交额5117.69万港元。中国生物制药所在的制药行业中，个股表现普遍走弱，翰森制药跌3.54%，石药集团跌3.57%，绿叶制药跌10.8%，康哲药业跌0.44%，恒瑞医药跌2.5%。中国生物制药有限公司是一家主要从事制药业务的投资控股公司，通过中药现代制剂及西药、投资、其他三个分部运营，核心业务涵盖创新药研发、生产、销售及配销。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179617925","title":"中國生物製藥（01177）披露Kylo-11 I期臨床結果：「一年一次」給藥潛力獲臨床證據支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179617925","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179617925?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 08:05","pubTimestamp":1788134730,"startTime":"0","endTime":"0","summary":"中国生物制药有限公司（01177）8月31日公告称，其全资附属公司杭州赫吉亚生物医药有限公司自主研发的国家1类创新药Kylo-11（LPA siRNA）I期临床研究最终结果已在2026年欧洲心脏病学会年会（ESC）以Late-Breaking Clinical Science口头报告形式发布，并同步发表于《柳叶刀》。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663602828","title":"中國生物製藥：創新藥Kylo-11 I期臨床數據在ESC 2026及《柳葉刀》公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2663602828","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663602828?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 08:03","pubTimestamp":1788134617,"startTime":"0","endTime":"0","summary":"中国生物制药：创新药Kylo-11 I期临床数据在ESC 2026及《柳叶刀》公布","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313859573668.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313859573668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1521","BK1574","IBBQ","HK0000165453.HKD","LNGR","BK1589","BK1191","BK1161","BK1515","06978","159992","MEDX","01177","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068895","title":"中國生物製藥：LM-364獲NMPA及FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068895","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068895?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 16:36","pubTimestamp":1787906160,"startTime":"0","endTime":"0","summary":"南财智讯8月28日电，中国生物制药（01177.HK）发布自愿公告，公司全资附属公司礼新医药科技（上海）有限公司自主研发的国家1类创新药LM-364“NECTIN-4TMEADC”已获得中国国家药品监督管理局（NMPA）临床试验默示许可，拟用于晚期实体瘤治疗；此前于2026年4月已获美国食品药品监督管理局（FDA）临床试验许可，并在澳大利亚正式启动临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608283858178370.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608283858178370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1589","BK1515","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1521","BK1191","IE00BZ08YT58.USD","BBC","HK0000165453.HKD","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181187318","title":"中國生物製藥（01177）自主研發LM-364獲NMPA臨床試驗默示許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1181187318","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181187318?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 16:35","pubTimestamp":1787906137,"startTime":"0","endTime":"0","summary":"2026年8月28日，中国生物制药有限公司公告称，其全资子公司礼新医药科技（上海）有限公司自主研发的国家1类创新药LM-364“NECTIN-4TMEADC”获得中国国家药品监督管理局临床试验默示许可，拟用于晚期实体瘤治疗。LM-364已于2026年4月获美国食品药品监督管理局临床试验许可，并在澳大利亚正式启动临床试验。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197341633","title":"中國生物製藥LM-364「Nectin-4TME ADC」獲NMPA臨床試驗批准，劍指晚期實體瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1197341633","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197341633?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 16:33","pubTimestamp":1787905999,"startTime":"0","endTime":"0","summary":"中国生物制药传来重磅消息——其研发的LM-364“Nectin-4TME ADC”药物，已正式获得国家药品监督管理局的临床试验许可。这一批准，标志着该创新药有望在晚期实体瘤治疗领域开启全新探索。此次获准开展临床试验，意味着中国生物制药在ADC赛道的布局再落一子，也为晚期实体瘤患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","BK1521","BK1589","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","HK0000165453.HKD","BK1191","IE00BZ08YT58.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150901640","title":"異動解讀｜中國生物製藥盤中下跌3.05%，報5.56港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150901640","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150901640?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 10:19","pubTimestamp":1787797162,"startTime":"0","endTime":"0","summary":"8月27日，中国生物制药盘中下跌3.05%，报5.56港元/股，成交额9562.55万港元。中国生物制药所在的制药行业中，个股表现分化，翰森制药涨14.11%，石药集团涨0.32%，长风药业涨2.74%，恒瑞医药跌0.86%，四环医药跌7.36%。中国生物制药有限公司是一家主要从事制药业务的投资控股公司，通过中药现代制剂及西药、投资、其他三个分部运营，核心业务涵盖创新药研发、生产、销售及配销。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729977","title":"【券商聚焦】國投證券：創新藥有望開啓新一輪高景氣周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729977","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662729977?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 09:29","pubTimestamp":1787794154,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国投证券研究指，医药景气新周期背景下，国内创新药产业链加速崛起。近年国家多举措全链条支持创新药发展，叠加国内得天独厚的人才储备和研发效率等多维优势，国内创新药持续加速崛起且逐步具备全球竞争力。与此同时，海外MNC陆续面临专利悬崖困境，对外采购和扩充创新管线需求与日俱增，国内创新药企顺势而为，以海外授权BD等形式实现创新出海，创新药有望开启新一轮高景气周期。风险提示：产品研发及审批速度低于预期；产品降价超预期风险；海外BD授权不及预期风险；计算及假设不及预期风险。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989630","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","IE0008369823.USD","LU1770034418.SGD","LU0516422952.EUR","LU0634319403.HKD","BK1589","LU1226287875.USD","06185","01093","LU0455707207.USD","161027","06160","LU0348767384.USD","SG9999002562.SGD","LU0140636845.USD","LU0051755006.USD","02269","LU0307460666.USD","LU2242644610.SGD","LU0880133367.SGD","09688","SG9999004220.SGD","01177","LU1813983027.USD","LU1794554557.SGD","01877","01801","09926","LNGR","LU0463099449.HKD","LU0326950275.SGD","02142","LU0348783233.USD","IBBQ","MEDX","LU0314109678.HKD","09995","LU0417516738.SGD","LU1969619763.USD","LU0348825331.USD","159992","IE00BPRC5H50.USD","KURE","LU0516423091.SGD","LU1807302812.USD","LU0039217434.USD","06978","02616","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662318714","title":"中國生物製藥減重「貼片」新藥在美國獲批臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2662318714","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662318714?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 20:05","pubTimestamp":1787745900,"startTime":"0","endTime":"0","summary":"近日，中国生物制药宣布CPX301可溶微针获美国FDA临床试验默示许可，拟用于体重管理。CPX301是中国生物制药核心企业北京泰德制药研发的GLP-1受体激动剂可溶微针贴片，具有给药便捷、递送高效、无菌安全、储运便利的特点，有望为需要长期体重管理的人群提供一种新的给药选择。新闻稿介绍，作为“真·可溶”微针（dissolving microneedle patch），CPX301针体采用生物相容性材料，及严格无菌生产工艺，患者贴敷5分钟后，微针便可完全溶解，随即可移除贴片。运营｜廿十三","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-26/doc-iniprytq2439307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01177","HK0000165453.HKD","BK1589","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1191","BK1521","IE00BZ08YS42.EUR","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109664310","title":"異動解讀｜中國生物製藥盤中上漲3.29%，GLP-1減重貼片獲美國FDA臨床批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1109664310","media":"行情直击","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109664310?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 09:46","pubTimestamp":1787708817,"startTime":"0","endTime":"0","summary":"8月26日，中国生物制药盘中上涨3.29%，报5.795港元，成交额1.79亿港元。消息面上，公司宣布其核心企业北京泰德制药研发的GLP-1受体激动剂可溶微针贴片CPX301获美国FDA临床试验默示许可，拟用于体重管理。该产品具备给药便捷、递送高效、无菌安全等特点，有望为长期体重管理人群提供新型给药选择。此外，公司旗下正大天晴自主研发的TQF6422注射液亦于近日获NMPA临床试验批准，同样聚焦肥胖及超重患者体重管理领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国生物制药大涨，GLP-1贴片获FDA临床批准","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662204818","title":"中國生物製藥減重「貼片」新藥在美國獲批臨床；益方生物重啓港股上市申請｜醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2662204818","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662204818?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 07:03","pubTimestamp":1787612588,"startTime":"0","endTime":"0","summary":"丨2026年8月25日星期二丨NO.1中国生物制药GLP-1减重“贴片”新药在美国获批临床中国生物制药宣布CPX301可溶微针获美国FDA临床试验默示许可，拟用于体重管理。CPX301是中国生物制药核心企业北京泰德制药研发的GLP-1受体激动剂可溶微针贴片，具有给药便捷、递送高效、无菌安全、储运便利的特点，有望为需要长期体重管理的人群提供一种新的给药选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608253851708095.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608253851708095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BZ08YT58.USD","KCAI","BK4585","BK1521","159938","01177","BK1161","BK1574","BK1589","HK0000165453.HKD","09939","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IPOS","VXUS","BK1515","BK4588","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244437","title":"【券商聚焦】交銀國際：中國內地mRNA疫苗產業整體低估嚴重","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244437","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661244437?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 09:18","pubTimestamp":1787534313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，Moderna与默沙东共同宣布，intismeran联合K药辅助治疗IIB-IV期黑色素瘤的III期INTerpath-001研究达主要终点 。该机构认为，中国内地mRNA疫苗企业正处于全球公共卫生事件后的低谷期，产业整体低估严重，但海外可比产品的研发成功和适应症领域的拓展有望推动投资情绪和估值修复。此外，康希诺、智飞生物/沃森生物/康华生物等布局mRNA技术、处于估值底部的疫苗企业也值得持续关注。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989096","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU1303224171.USD","LU0359201612.USD","LU0228659784.USD","LU0588546209.SGD","MRNX","09926","LU0181495838.USD","LU2488822045.USD","KCE","BK1588","LU0561508036.HKD","LU0244354667.USD","LU0348767384.USD","01877","LU1794554557.SGD","03329","LU1242518931.SGD","02616","BK1191","BK1147","KURE","LU0320764599.SGD","LU1226287792.SGD","LU1960683339.HKD","LU0880133367.SGD","02142","LU1008478684.HKD","LU2097828557.USD","01177","09688","LU0417516571.SGD","06160","BK1576","LU0348766576.USD","SG9999002562.SGD","06185","LU0516423174.USD","LU0307460666.USD","LU1688375341.USD","LU0067412154.USD","LU0828237510.HKD","01093","09995","BK1589","LU0979878070.USD","02269","MRNY","LU0043850808.USD","LU0516422366.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661824834","title":"中國生物製藥(01177.HK)創新ActRII A/B單抗獲准開展臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2661824834","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661824834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 18:05","pubTimestamp":1787479500,"startTime":"0","endTime":"0","summary":"中国生物制药(01177.HK) 公布，附属正大天晴自主研发的国家1类创新药TQF6422注射液“ActRII A/B单抗”获中国国家药品监督管理局药品审评中心批准开展临床研究，拟用于成人肥胖患者，或超重且合并至少一种体重相关合并症患者的体重管理。TQF6422临床前研究结果显示，体外活性较同类产品提升10倍以上，在多种动物药效模型中以更低剂量实现了更优的脂肪减少及瘦体重维持；联合GLP-1协同增效，减脂增肌双重获益；及药代动力学与安全性特征良好。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-08-21 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250730181922236_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250730181922236_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540038/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540038/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00BZ08YT58.USD","BK1191","BK1521","BK1515","IE00BZ08YS42.EUR","BK1589","HK0000165453.HKD","IE00BZ08YR35.GBP","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661426475","title":"中國生物製藥(01177)：TQF6422注射液「ActRII A/B單抗」臨床試驗申請獲NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2661426475","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661426475?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 18:35","pubTimestamp":1787308504,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，本集团附属公司正大天晴药业集团股份有限公司自主研发的国家1类创新药TQF6422注射液已获得中国国家药品监督管理局药品审评中心批准开展临床研究，拟用于成人肥胖患者，或超重且合并至少一种体重相关合并症患者的体重管理。因此，靶向ActRII通路具有同步改善脂肪量与瘦体重的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","MDTX","IE00BZ08YR35.GBP","BK1191","HK0000165453.HKD","IE00BZ08YS42.EUR","BMED","IBBJ","IE00BZ08YT58.USD","BK1589","PSYK","BK1515","IBBQ","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122294514","title":"中國生物製藥(01177)自主研發TQF6422注射液獲NMPA臨床試驗許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1122294514","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122294514?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 18:21","pubTimestamp":1787307669,"startTime":"0","endTime":"0","summary":"据中国生物制药有限公司2026年8月21日公告，其附属公司正大天晴药业集团股份有限公司自主研发的国家1类创新药TQF6422注射液已获国家药品监督管理局药品审评中心批准，可于中国境内开展临床研究，拟用于成人肥胖患者或超重并合并至少一种体重相关并发症患者的体重管理。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159609479","title":"中國生物製藥Tqf6422注射液「Actrii a/B單抗」臨床試驗申請獲國家藥監局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1159609479","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159609479?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 18:18","pubTimestamp":1787307494,"startTime":"0","endTime":"0","summary":"中国生物制药传来重磅消息——其Tqf6422注射液的临床试验申请，已正式获得国家药品监督管理局的批准。据悉，此次获批的临床试验申请，为中国生物制药在创新抗体药物领域的又一重要布局。Tqf6422注射液所涉的“Actrii a/B单抗”机制，瞄准了特定的疾病治疗路径，其临床价值备受市场期待。回望过去数月，中国生物制药在创新药研发上动作频频。此次Tqf6422注射液的临床申请获批，无疑是其研发策略持续深化的一个缩影。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ08YR35.GBP","BK1589","IE00BZ08YT58.USD","01177","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1191","BK1521"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}